To receive the Femtech World newsletter, sign up here.
News
Kate Middleton’s cancer diagnosis could ‘inspire change’ in women’s health
Princess of Wales’ cancer message has prompted a surge in visits to the websites of relevant charities and the NHS

Kate Middleton’s revelations about her cancer diagnosis could inspire change in women’s health, experts have said, a amid surge in online cancer symptom searches.
Visits to the NHS website cancer page rose by 373 per cent following the announcement that Princess Kate has been diagnosed with the disease.
Figures from NHS England show that in the 24 hours after the princess revealed she was undergoing treatment last week, there were 2,840 visits to the page on cancer – nearly five times as many as over the same period the previous week.
Now, experts have indicated that Kate’s diagnosis could increase global awareness and advance innovation in women’s health.
“Kate’s announcement could inspire and accelerate innovation in women’s health, the way Angelina Jolie’s double mastectomy procedure did after she learnt that she carried the BRCA gene,” Dr Olubukola Ayodele, consultant medical oncologist at University Hospitals of Leicester NHS Trust, told Femtech World.
Cancer diagnosis in public figures, Ayodele said, has always been a “catalyst” for spreading awareness.
“CRUK and Macmillan have seen a spike in people visiting their websites to read about signs and symptoms of cancer. Hopefully, [Kate’s diagnosis] would encourage women to come forward sooner if things are not feeling right.
“Unfortunately, incidental diagnosis of cancer is quite common, especially after a routine surgical procedure and only after examination of the surgical specimen, that cancer is found,” she added.
“The incidence of cancer in young women under the age of 50 is on the increase and there are twice as many cases in females compared to males in this age group.
“It is imperative that we focus on the message that young people need to be aware that they are also at risk. Cancer is no longer an older person disease.”
Erin Medlin, gynaecologic oncologist at Colorado Permanente Medical Group, said: “Celebrities and public figures do play a role in destigmatising women’s health issues as well as other health issues. We have seen similar trends before when celebrities have disclosed cancer diagnoses or treatments, as well as other illnesses.
“When celebrities disclose an illness, it can help others seek more information and raise awareness. It may bring forward those who have been suffering to seek more information or share their stories.”
Celebrities, Medlin said, could also raise awareness in policy makers, legislators and industry, bringing funding to research campaigns through public awareness.
However, she said a celebrity’s story does not translate to an individual patient’s or person’s story.
“Patients should always seek guidance from their physician or health care provider, and seek out reliable sources for information.”
Michelle Mitchell, chief executive of Cancer Research UK, said high-profile cancer cases can encourage people to take action and seek help.
“There were over 200,000 visits to our cancer information web pages on the day of the Princess’s diagnosis. This was a 15 per cent increase compared to the day before the announcement.
“These figures show how high-profile cancer cases can act as a prompt to encourage people to find out more or think about their own health.”
Noting that visits to Macmillan Cancer Support’s online information and support pages were at the highest weekend levels since the first Covid lockdown following the Princess of Wales’ cancer message, Gemma Peters, chief executive of Macmillan Cancer Support, said the “Kate Middleton effect” could have a real-world impact.
“We hear from people every day who are worried about how cancer will affect their loved ones, and how best to support each other through it. In sharing her news the Princess of Wales has raised awareness of these worries and will be helping to encourage others who have concerns, to seek support.”
Adolescent health
Newly-launched Female Health Hub will support grassroots football players

A new Female Health Hub launched by the English FA will support women and girls in grassroots football in England with trusted advice on health issues affecting play.
The hub brings together expert-backed guidance, practical tools and player insights in one place, giving women and girls practical advice and reassurance on female health in football.
It has four core aims: to help women and girls better understand their bodies and how female health affects performance and participation, to educate players on key health topics and when to seek further advice or support, to provide practical strategies to help navigate common female health challenges, and to help break down taboos and normalise conversations around female health in football.
Users of the hub will also be able to hear directly from members of the England women’s national team, who share their own experiences of navigating female health matters while playing at the highest level of the game.
“Our ambition is to create a game where women and girls can thrive,” said Sue Day, the FA’s director of women’s football.
“To achieve that, it’s essential that players feel supported in environments that understand and respond to their female health needs.
“We’ve heard directly from grassroots players that they want better information and support around female health, but that they often don’t know where to find it.
“The launch of the Female Health Hub marks an important step in changing the landscape.
“We want every player to feel confident in her own skin and supported without judgment, so she can feel empowered by her body, rather than held back by it.”
The platform was launched following research conducted by the FA that highlighted the need for better education and support around female health in football.
According to the FA, 88 per cent of adult players surveyed said their menstrual cycle has an impact on their ability to train or play, but 86 per cent reported they had never received education about the menstrual cycle in relation to football performance and training.
The research also found 64 per cent of women experience issues related to sports bras or breast health while playing football, despite sports bras being considered one of the most important pieces of playing kit.
Players also expressed strong interest in learning more about injury prevention, at 87 per cent, nutrition, at 84 per cent, and mental health, at 77 per cent, in relation to female health.
The first phase of the Female Health Hub focuses on three of the most requested topics: menstrual health, breast health and injury resilience, with further content to follow, including nutrition and pelvic health guidance.
Pregnancy
Women’s health strategy a ‘missed opportunity,’ RCM says
Fertility
Genetic carrier screening before pregnancy: What to know

Article produced in association with London Pregnancy Clinic and Jeen Health
For the majority of couples planning a pregnancy, genetic testing is not something they think about until a problem arises.
Pre-conception genetic carrier screening challenges this approach by identifying risk before pregnancy begins.
As panel sizes have grown and at-home testing options have become widely available, carrier screening is transitioning from a niche clinical referral into a mainstream component of reproductive planning.
What Carrier Screening Tests For
Being a carrier of a genetic condition means carrying one copy of a variant in a gene associated with that condition, without being affected by it.
In most cases, carriers are entirely unaware of their status.
The clinical significance of carrier status emerges when both members of a couple carry a variant in the same gene: in this scenario, each pregnancy carries a one in four chance of resulting in a child who inherits two copies of the variant and is affected by the condition.
The conditions most frequently included in expanded carrier screening panels include cystic fibrosis, spinal muscular atrophy (SMA), fragile X syndrome, sickle cell disease, and a range of metabolic and enzyme deficiency disorders.
The Beacon 787 carrier test, offered by Jeen Health, screens for 787 conditions from a single sample, making it one of the most comprehensive panels currently available to UK families.
Who Is Most Likely to Benefit
Any couple planning a pregnancy can consider carrier screening. It is particularly relevant for:
- Couples with a family history of a known inherited condition
- Those from populations with higher carrier frequencies for specific conditions, including Ashkenazi Jewish, South Asian and African communities
- Couples pursuing fertility treatment, where genetic information informs treatment planning
- Those who wish to have the most complete picture of their reproductive health before conception
Importantly, being a carrier of a condition does not mean a child will be affected. It means there is a defined statistical risk that can be quantified, discussed and planned for with appropriate clinical support.
How the Test Is Performed
Carrier screening is typically carried out on a blood or saliva sample.
For at-home options such as the testing offered by Jeen Health, a cheek swab collection kit is dispatched to the patient, the sample is returned by post, and results are delivered digitally within a defined turnaround period.
In-clinic carrier testing may use a blood draw and provides the advantage of immediate access to a clinical consultation at the point of result delivery.
London Pregnancy Clinic offers genetics counselling through its partnership with Jeen Health, allowing couples to receive and contextualise carrier test results with expert support.
Genetic counselling before and after testing is recommended by Genomics England as a standard component of any genomic testing pathway.
What Happens If Both Partners Are Carriers
If both partners are identified as carriers for the same autosomal recessive condition, they are typically offered further counselling to discuss their options.
These may include proceeding naturally with an awareness of the risk, using prenatal diagnosis (CVS or amniocentesis) during pregnancy to test the fetus, or pursuing preimplantation genetic testing (PGT) in the context of IVF, which allows unaffected embryos to be selected before transfer.
The purpose of identifying carrier status before pregnancy is to give couples time to consider these options without the added pressure of an ongoing pregnancy.
Knowledge of carrier status does not remove reproductive choices; it expands the information available when making them.
The Role of Pre-Conception Services
Carrier screening sits within a broader category of pre-conception care that includes fertility assessments, general health optimisation and, where relevant, management of existing conditions before pregnancy begins.
London Pregnancy Clinic offers pre-conception services encompassing fertility investigations, genetics counselling and carrier testing as part of an integrated 0th trimester approach, allowing couples to address genetic and clinical risk factors before their pregnancy starts rather than after.
Disclaimer: This article is produced for informational purposes only and does not constitute medical advice, diagnosis or treatment.
Clinical guidance referenced reflects published NHS, NICE and RCOG standards as at March 2026. Individual circumstances vary; readers are advised to consult a qualified healthcare professional before acting on any information in this article.
This piece was produced in association with London Pregnancy Clinic and Jeen Health, which provided background clinical information for editorial purposes.
Hyperlinks to external sources are included for reference only and do not represent an endorsement of any product, service or organisation.
Entrepreneur2 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Menopause4 weeks agoCalifornia plans US$3.4m menopause care overhaul
Pregnancy3 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
Menopause3 weeks agoWatchdog bans five ads for women’s heath claims
Entrepreneur4 weeks agoWHIS USA 2026 announces first ticket release for landmark Women’s Health Innovation Summit
Menopause4 weeks agoMenopause has no lasting impact on cognition, research finds
News2 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Opinion3 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up
















1 Comment